Get startedLog in
    Picture of Actinium Pharmaceuticals logo

    ATNM — Actinium Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapSucker Stock
    All News

    Brief: Actinium Pharmaceuticals Inc Says Awarded Grant By National Institutes Of Health To Study Novel Iomab-Act Targeted Conditioning With A Cd19 Car T-Cell Therapy

    Picture of Actinium Pharmaceuticals logoActinium Pharmaceuticals
    21/10/2020 12:09
    Oct 21 (Reuters) - Actinium Pharmaceuticals Inc  ATNM.A :
    * ACTINIUM PHARMACEUTICALS, INC. AWARDED GRANT BY NATIONAL
INSTITUTES OF HEALTH TO STUDY NOVEL IOMAB-ACT TARGETED
CONDITIONING WITH A CD19 CAR T-CELL THERAPY

Source text for Eikon:  ID:nPn7yD2fDa 
Further company coverage:  ATNM.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Actinium Pharmaceuticals

    See all news